Technology | Flat Panel Displays | November 02, 2016

Eizo Releases 5 Megapixel RadiForce GX550 Medical Monitor for Breast Tomosynthesis

Sharpness Recovery technology restores image quality typically lost with increased monitor brightness

Eizo, RadiForce GX550 medical monitor, FDA approval, digital breast tomosynthesis, DBT, mammography, RSNA 2016

November 2, 2016 — Eizo Inc. announced the release of the RadiForce GX550, a 21.3-inch, 5 megapixel monitor for viewing detailed digital breast tomosynthesis and mammography images. It is the successor model to the RadiForce GX540 and features superior imaging capability and ease-of-use.

A medical monitor needs to be capable of high brightness in order to meet performance standards. However, in order to achieve high brightness in an LCD panel, the pixel aperture ratio has to be increased. This causes a typically unavoidable decline in sharpness. The RadiForce GX550 features Eizo’s Sharpness Recovery technology, with which the decrease in sharpness (MTF) is restored. This allows healthcare professionals to display an image safely on the monitor that is true to the original source data, even at high brightness levels.

The monitor’s new design features thinner, black front bezels, making it easier to focus on images in dark reading rooms, while the original white stripe design around the sides of the monitor presents a fresh, clean aesthetic to promote a comfortable, user-friendly environment. For keeping the workspace efficient, the monitor’s width, height and depth were reduced by 21 mm, 36 mm and 45.5 mm respectively – a 28 percent difference compared to its predecessor. The width of the side bezels was reduced by approximately half to 13.5 mm – the thinnest in the industry for 5 megapixel monitors, according to Eizo. This allows users to comfortably view two monitors side by side to compare images.

The company has received U.S. Food and Drug Administration (FDA) 510(k) clearance for digital breast tomosynthesis and digital mammography for the RadiForce GX550. Digital breast tomosynthesis is a method of breast screening that allows the radiologist to view detailed three-dimensional images of the breast assembled from multiple X-ray pictures. When used in combination with digital mammography, tomosynthesis provides radiologists with multiple screening techniques that can be utilized together for increased diagnostic precision in breast cancer detection.

Eizo will be showing the RadiForce GX550 at the 2016 Radiological Society of North America annual meeting (RSNA 2016), Nov. 27-Dec. 1 in Chicago.

The new monitor will begin shipping in December.

For more information: www.eizo.com

Related Content

Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
The MOZART Supra Specimen Tomosynthesis System is the latest generation of 3-D imaging for breast cancer surgery.
News | Breast Imaging | November 08, 2018
KUBTEC announced the launch of a new innovation in the treatment of breast cancer. The Mozart Supra Specimen...
Feature | Breast Imaging | November 07, 2018 | By Jeff Zagoudis
Breast imaging technology has experienced major growth over the last decade or so, and a new report suggests the mark
Philips’ Compressed SENSE technology helps shorten MRI exams by eliminating redundant radiofrequency signals from the acquisition phase. The software reconstructs any missing  information to maintain high image quality. (Images courtesy of Philips/University Hospital Cologne)

Philips’ Compressed SENSE technology helps shorten MRI exams by eliminating redundant radiofrequency signals from the acquisition phase. The software reconstructs any missing information to maintain high image quality. (Images courtesy of Philips/University Hospital Cologne)

Feature | Breast Imaging | November 05, 2018 | By Jeff Zagoudis
The incidence of breast cancer is rising globally, with an estimated 1 in 8 women diagnosed in their lifetime and 40,...
Deaconess Health System Chooses Sectra as Enterprise Imaging Vendor
News | Enterprise Imaging | November 02, 2018
International medical imaging information technology (IT) and cybersecurity company Sectra will install its enterprise...
Volpara Enterprise Cloud Reaches 1 Million Mammograms Stored
News | Mammography | October 31, 2018
Volpara Solutions announced that the data stored in the Volpara Enterprise cloud now exceeds 1 million mammographic...
Etta Pisano Named American College of Radiology Chief Research Officer
News | Radiology Business | October 25, 2018
October 25, 2018 — Breast imaging research pioneer Etta Pisano, M.D., FACR, has been named...
DenseBreast-info.org Launches Patient Education Video Series
News | Breast Density | October 24, 2018
DenseBreast-info.org (DB-I) announced the release of "Let's Talk About Dense Breasts," a series of three informational...
Fewer, larger individual doses of radiation lead to similar adverse effects to normal tissue after 10 years as with conventional radiation therapy for early breast cancer
News | ASTRO | October 22, 2018
In a 10-year study of women who received radiation therapy to treat early-stage breast cancer, those receiving fewer,
DCIS, ductal carcinoma in situ, radiation therapy, survival benefit, Brigham and Women's Hospital study. #ASTRO2018 #ASTRO #ASTRO18

Image courtesy of Barco

News | ASTRO | October 21, 2018
A subset of patients with low-risk breast cancer is highly unlikely to see cancer return following breast conservatio